MedTrace Logo

Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers

NCT01528774 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2017-07-26

No results posted yet for this study

Summary

The purpose of this study is to determine if circulating tumor cells (CTC) can be accurately detected and isolated from the blood of participants with melanoma using novel laboratory techniques. Blood samples will be collected from participants with melanoma, and also from participants with other solid tumor cancers and healthy volunteers for purposes of comparison.

Relevant information will be collected from participant's medical record and stored in a coded manner in a password-protected format. This information will be used to look for correlations of research results on blood samples to participant's medical condition. Test results will not be given to participants or their physicians. In some cases, CTC may be grown for long-term cell lines for further research.

Conditions

Interventions

OTHER

Blood Draw

Approximately 40 cc of blood will be drawn from participants at a time when they are having blood drawn for routine or treatment-related purposes. Sequential samples may be obtained in the same manner from selected patients to allow exploration of potential correlation of CTC with response to treatment, progression-free survival and overall survival.

Sponsors & Collaborators

  • TrueCells, LLC

    collaborator INDUSTRY

  • Comprehensive Cancer Centers of Nevada

    collaborator OTHER

  • University of Pittsburgh

    collaborator OTHER

  • Wolfram Samlowski

    lead OTHER

Principal Investigators

  • Wolfram Samlowski, MD · Comprehensive Cancer Centers of Nevada

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01528774 on ClinicalTrials.gov